<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02859194</url>
  </required_header>
  <id_info>
    <org_study_id>4-2016-0124</org_study_id>
    <nct_id>NCT02859194</nct_id>
  </id_info>
  <brief_title>The Effect of Lt to Rt Shunt Using Veno-veno-arterial Extracorporeal Membrane Oxygenation (ECMO) on Coronary Oxygenation in Lung Transplantation Patients</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yonsei University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yonsei University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      ECMO(Extracorporeal membrane oxygenation) is being essential for cardiopulmonary failure
      patients. There are two types of ECMO, which is veno-veno (V-V) that can be used in
      respiratory failure patients and veno-arterial (V-A) that can be used in cardiac failure
      patients. V-A ECMO can also be used during lung transplantation, substitution of
      cardiopulmonary bypass, which can show sufficient performance during operation and better
      postoperative outcome. However, regarding V-A ECMO circulating from femoral vein to femoral
      artery, there is a pro blem of differential hypoxia which might influence coronary artery and
      head vessels. In this prospective study, the investigators are planning to put another ECMO
      catheter into internal jugular vein which takes a role of left to right shunt, to mitigate
      the hypoxia of coronary artery.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2016</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>arterial blood oxygen partial pressure (PaO2)</measure>
    <time_frame>5 min after jugular catheter flow 0ml/min</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>arterial blood oxygen partial pressure (PaO2)</measure>
    <time_frame>5 min after jugular catheter flow 500 ml/min</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>arterial blood oxygen partial pressure (PaO2)</measure>
    <time_frame>5 min after jugular catheter flow 1,000ml/min</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>arterial blood oxygen partial pressure (PaO2)</measure>
    <time_frame>5 min after jugular catheter flow 1,500ml/min</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>venous blood oxygen partial pressure (PvO2)</measure>
    <time_frame>5 min after jugular catheter flow 0ml/min</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>venous blood oxygen partial pressure (PvO2)</measure>
    <time_frame>5 min after jugular catheter flow 500 ml/min</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>venous blood oxygen partial pressure (PvO2)</measure>
    <time_frame>5 min after jugular catheter flow 1,000ml/min</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>venous blood oxygen partial pressure (PvO2)</measure>
    <time_frame>5 min after jugular catheter flow 1,500ml/min</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Interstitial Pulmonary Fibrosis ARDS</condition>
  <condition>COPD (Chronic Obstructive Pulmonary Disease)</condition>
  <condition>Bronchiectasis</condition>
  <condition>Lymphangioleiomyomatosis</condition>
  <condition>Primary Pulmonary Hypertension</condition>
  <condition>ARDS (Acute Respiratory Distress Syndrome)</condition>
  <arm_group>
    <arm_group_label>Veno-veno-arterial ECMO group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Veno-veno-arterial ECMO</intervention_name>
    <arm_group_label>Veno-veno-arterial ECMO group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        1. scheduled for double lung transplantation

        Exclusion Criteria:

          1. patients who have history of coronary artery occlusive disease

          2. patients with arrhythmia
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Young Chul Yoo, Doctorate of Anesthesiology</last_name>
    <phone>82-2-2228-7897</phone>
    <email>SEAOYSTER@yuhs.ac</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Anesthesiology and Pain Medicine, Anesthesia and Pain Research Institue, Yonsei Universiy College of Medicine</name>
      <address>
        <city>Seoul</city>
        <zip>120-752</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Young Chul Yoo, MD</last_name>
      <phone>82-2-2228-2420</phone>
      <email>seaoyster@yuhs.ac</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>July 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 21, 2016</study_first_submitted>
  <study_first_submitted_qc>August 3, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 8, 2016</study_first_posted>
  <last_update_submitted>August 3, 2016</last_update_submitted>
  <last_update_submitted_qc>August 3, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 8, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
    <mesh_term>Hypertension, Pulmonary</mesh_term>
    <mesh_term>Respiratory Distress Syndrome, Newborn</mesh_term>
    <mesh_term>Respiratory Distress Syndrome, Adult</mesh_term>
    <mesh_term>Pulmonary Fibrosis</mesh_term>
    <mesh_term>Acute Lung Injury</mesh_term>
    <mesh_term>Bronchiectasis</mesh_term>
    <mesh_term>Lymphangioleiomyomatosis</mesh_term>
    <mesh_term>Familial Primary Pulmonary Hypertension</mesh_term>
    <mesh_term>Lung Diseases, Interstitial</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

